| Business Name: |
Novobiotic Pharmaceuticals LLC |
| Contact Person: |
Aram Salzman, Chief Executive Officer |
| Address: |
767 Concord Avenue, Cambridge, Massachusetts 02138 |
| Phone Number: |
(617) 864-2880 |
| Website Address: |
novobiotic.com |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Founding Year: |
2003 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Research and Development Laboratories |
| SIC Code: |
8731 |
| NAICS Code: |
6213400 |
| Share This Business: |
|
| Related Businesses: |
Hyperion Catalysis International Inc - Cambridge, MA 02138
Cellendyne - Cambridge, MA 02138
Molecmo Nanobiotechnologies - Cambridge, MA 02138
Cromesett Energy Technologies LLC - Cambridge, MA 02138
Jounce Therapeutics Inc - Cambridge, MA 02138
Soane Labs LLC - Cambridge, MA 02138
Avogadro Inc - Cambridge, MA 02138
Bnw Technologies - Cambridge, MA 02138
Cambridge Chemical Techs - Cambridge, MA 02138
Radcliff - Cambridge, MA 02138
Quintiles - Cambridge, MA 02138
Boston Micromachines Corp - Cambridge, MA 02138
Soane Energy LLC - Cambridge, MA 02138
Hstar Technologies Corp - Cambridge, MA 02138
|
The company Novobiotic Pharmaceuticals LLC provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts.
1 to 4 employees work for Novobiotic Pharmaceuticals LLC, and the business now earns $500.000 to $999.999 per annum.
Novobiotic Pharmaceuticals LLC was launched in 2003 and is classified under SIC code and category 8731 , and NAICS number and grouping 6213400 .
To contact Novobiotic Pharmaceuticals LLC, please call Aram Salzman, Chief Executive Officer with the phone number (617) 864-2880 or visit its single location at 767 Concord Avenue in Cambridge, Massachusetts 02138.
The location of the single location can also be found using the coordinates 42.39195,-71.15441.
Read more details about this business on the webpage novobiotic.com or follow the company’s social media accounts, on Twitter and on Facebook.